首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Pharmacokinetic/Pharmacodynamic Analysis of the Influence of Inoculum Size on the Selection of Resistance in Escherichia coli by a Quinolone in a Mouse Thigh Bacterial Infection Model
【2h】

Pharmacokinetic/Pharmacodynamic Analysis of the Influence of Inoculum Size on the Selection of Resistance in Escherichia coli by a Quinolone in a Mouse Thigh Bacterial Infection Model

机译:小鼠大腿细菌感染模型中接种量对喹诺酮类药物对大肠杆菌耐药性选择的影响的药代动力学/药效学分析。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Maintaining quinolone concentrations outside the mutant selection window (MSW) between the MIC and mutant prevention concentration (MPC) was suggested by in vitro and in vivo studies to prevent the selection of resistant mutants. However, selection also may depend on the presence of resistant bacterial mutants at the start of treatment, which is highly dependent on the initial inoculum size. In this study, a mouse thigh bacterial infection model was used to test the influence of different exposures to marbofloxacin on the selection of resistant bacteria after infection with a low (105 CFU) or high (108 CFU) initial inoculum of Escherichia coli. The inoculum size was shown to influence the exposure to marbofloxacin and the values of pharmacokinetic/pharmacodynamic indices. When the abilities of the indices time within the MSW (TMSW), area under the concentration-time curve of 0 to 24 h divided by the MIC, and the maximum concentration of drug in plasma divided by the MIC to predict the selection of resistant bacteria were compared, only TMSW appeared to be a good predictor of the prevention of resistance for values less than 30%. When the TMSW was higher than 34%, the selection of resistant bacteria occurred less often in thighs initially infected with the low inoculum (11/24; 46%) than in those infected with the high inoculum (30/36; 80%), suggesting that the selection of resistant mutants depends on both the TMSW and inoculum size. The relevance of these results merits further investigation to test different strategies of antibiotic therapy depending on the expected bacterial burden at the infectious site.
机译:体外和体内研究表明,应将喹诺酮浓度保持在MIC和突变预防浓度(MPC)之间的突变选择窗(MSW)之外,以防止选择抗性突变体。但是,选择也可能取决于治疗开始时耐药细菌突变体的存在,这在很大程度上取决于初始接种量。在这项研究中,使用小鼠大腿细菌感染模型来测试在低(10 5 CFU)或高(10 8 CFU)大肠杆菌的初始接种物。已显示接种物的大小会影响对马波沙星的暴露以及药代动力学/药效学指标的值。当指标的能力在MSW(TMSW)内计时时,浓度-时间曲线下的面积在0至24 h内除以MIC,血浆中最大药物浓度除以MIC来预测耐药菌的选择进行比较后,只有TMSW似乎是小于30%的抗药性的良好预测指标。当TMSW高于34%时,在最初感染低接种量的大腿(11/24; 46%)中发生抗药性细菌的频率比感染高接种量的大腿(30/36; 80%)的发生率低,这表明抗性突变体的选择取决于TMSW和接种量。这些结果的相关性值得进一步研究,以根据感染部位的预期细菌负荷来测试抗生素治疗的不同策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号